1. Home
  2. NVEC vs FULC Comparison

NVEC vs FULC Comparison

Compare NVEC & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NVE Corporation

NVEC

NVE Corporation

HOLD

Current Price

$119.36

Market Cap

437.4M

Sector

Technology

ML Signal

HOLD

Logo Fulcrum Therapeutics Inc.

FULC

Fulcrum Therapeutics Inc.

HOLD

Current Price

$3.84

Market Cap

467.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVEC
FULC
Founded
1989
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
437.4M
467.8M
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
NVEC
FULC
Price
$119.36
$3.84
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
$16.38
AVG Volume (30 Days)
250.5K
1.5M
Earning Date
05-06-2026
04-27-2026
Dividend Yield
5.13%
N/A
EPS Growth
0.96
N/A
EPS
1.32
N/A
Revenue
$26,331,218.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$95.41
N/A
Revenue Growth
1.76
N/A
52 Week Low
$57.21
$2.83
52 Week High
$135.00
$15.74

Technical Indicators

Market Signals
Indicator
NVEC
FULC
Relative Strength Index (RSI) 63.44 51.59
Support Level $81.02 $3.44
Resistance Level $135.00 $4.02
Average True Range (ATR) 9.52 0.14
MACD 1.84 0.05
Stochastic Oscillator 85.39 82.95

Price Performance

Historical Comparison
NVEC
FULC

About NVEC NVE Corporation

NVE Corp is engaged in developing and selling devices that use spintronics, a nanotechnology that relies on electron spin rather than electron charge to acquire, store, and transmit information. It manufactures high-performance spintronic products including sensors and couplers that are used to acquire and transmit data. The company's products include Digital sensors, Medical sensors, Rotation Sensors, GT Sensors, Angle Sensors, Analog sensors, MSOP Isolators, Passive-In Transceivers, and others. The company manufactures high-performance spintronic products including sensors and couplers. The company's designs are based on giant magnetoresistance GMR and tunneling magnetoresistance TMR combined with integrated circuitry.

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.

Share on Social Networks: